Kinomica is a proteomic-data science and diagnostics company specialising in cell signalling. We offer KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage.
We offer KScan™ for:
- Improved monitoring of drug molecular efficacy and response (to fully elucidate mode of action and mechanisms of resistance).
- Discovery of predictive biomarkers for patient selection and stratification in clinical trials.
Kinomica’s approach to measuring the phosphorylation signature of proteins, rather than using gene expression, provides a direct snapshot of protein and cell-signalling activity. We have preclinical proof-of-concept data to demonstrate that our game-changing biomarkers predict drug response more accurately than current state-of-the-art gene sequencing.